Associate Professor Gethin Thomas has over 20 years experience in research and research management across universities, research institutes and the private sector.
He undertook his undergraduate and PhD studies in the Department of Biology at the University of Birmingham in the UK, graduating with a PhD in Bone Cell Biology. He then undertook post-doctoral studies at the University of California in San Diego for two years followed by five years at the Garvan Institute. Dr Thomas then moved to industry spending five years with a biotechnology company in Montréal where he identified two novel bone genes, Ostn and Bril. Ostn being patented and targeted for drug development and Bril being identified as the gene mutated in osteogenesis imperfecta type V. In 2005, Dr Thomas returned to academia in Australia leading the Musculoskeletal Biology Group at the University of Queensland Diamantina Institute (UQDI).
In 2011, he also took on the Deputy Director of Education role at UQDI taking responsibility for the institute’s RHD student cohort, as well as sitting on faculty and university level RHD committees. Since this time he had continually developed his interest in the RHD management space doubling the size of the UQDI student cohort and establishing a number of new programs. He has extensive knowledge of the granting system having held 3 NHMRC grants as CIA as well as a number of other grants from other bodies. He has also served on grant review panels for the NHMRC, Arthritis Australia and the Rebecca Cooper Foundation as well as reviewing grants for a number of International funding bodies.